As a Free StocksGuide user, you can view scores for all 7,008 stocks worldwide.
19 Analysts have issued a SCHOTT Pharma forecast:
19 Analysts have issued a SCHOTT Pharma forecast:
Jun '25 |
+/-
%
|
||
Revenue | 976 976 |
3%
3%
|
|
Gross Profit | 329 329 |
2%
2%
|
|
EBITDA | 265 265 |
15%
15%
|
EBIT (Operating Income) EBIT | 190 190 |
12%
12%
|
Net Profit | 147 147 |
2%
2%
|
In millions EUR.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Head office | Germany |
CEO | Andreas Reisse |
Employees | 4,775 |
Founded | 2022 |
Website | www.schott-pharma.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.